Cited by 279Computational Drug Discovery MethodsMachine Learning in Materials ScienceProtein Degradation and Inhibitors

Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery

Open access
Polykovskiy, Daniil, Zhebrak, Alexander, Vetrov, Dmitry, Ivanenkov, Yan, Aladinskiy, Vladimir, Mamoshina, Polina, Bozdaganyan, Marine, Aliper, Alexander +2 more·2018·Molecular Pharmaceutics

Abstract

Modern computational approaches and machine learning techniques accelerate the invention of new drugs. Generative models can discover novel molecular structures within hours, while conventional drug discovery pipelines require months of work. In this article, we propose a new generative architecture, entangled conditional adversarial autoencoder, that generates molecular structures based on various properties, such as activity against a specific protein, solubility, or ease of synthesis. We apply the proposed model to generate a novel inhibitor of Janus kinase 3, implicated in rheumatoid arthritis, psoriasis, and vitiligo. The discovered molecule was tested in vitro and showed good activity and selectivity.

Integrity signals

Registry

Crossref · 10.1021/acs.molpharmaceut.8b00839

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hopfinger framed this discussion in terms of computer-aided drug design in 1985.

    “Hopfinger (100) framed this discussion in terms of computer-aided drug design in 1985.”

    From Artificial Intelligence for Drug Discovery: Are We There Yet? (2024) · cites this paper as [100]

Cites

Flagged first, then by citations

2 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A.
Affiliations
  • National Research University Higher School of Economics (RU)
  • Insilico Medicine (United States) (US)
  • Russian Academy of Sciences (RU)
  • Moscow Institute of Physics and Technology (RU)
Corresponding author
Polykovskiy, Daniil
Venue
Molecular Pharmaceutics
Published
2018-09-04
Volume
15
Issue
10
Pages
4398-4405
ISSN
  • 1543-8384 (ISSN-L)
  • 1543-8392
OpenAlex
W2891868449
Cited by
278
References
52
Citations by year
2026: 20 · 2025: 32 · 2024: 46 · 2023: 39 · 2022: 24 · 2021: 43 · 2020: 42 · 2019: 27 · 2018: 4 · 2017: 1
FWCI
21.88
Type
journal article
Language
en
Open access
Locations
  • Molecular Pharmaceutics (publishedVersion, other-oa)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education and Science of the Russian Federation (20.9907.2017/VU)
  • Russian Science Foundation (17-71-20072, 17-74-30012)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Keywords
generative models, de novo drug discovery, molecular generation, rheumatoid arthritis, psoriasis, vitiligo, solubility, synthetic accessibility, drug-likeness
MeSH terms
Machine Learning, Animals, Humans, Neural Networks, Computer, Janus Kinase 3, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review